Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Re: BTI:TSXV; BIOAF:OTCQB: "Announces Rare Diseases Strategic Alliance With Chiesi"
"Deal provides Chiesi Group with worldwide, exclusive license to use Bioasis xB3 TM platform for delivery of undisclosed enzymes in treatment of four lysosomal storage disorders."
"Under terms of the agreement, Bioasis will receive an upfront payment of US$3 million, additional potential milestone payments of up to US$138 million and royalties on net sales from licensed products."
"Chiesi Group will be responsible for all costs associated with research, development and commercialization of the four undisclosed LSD programs."
"Chiesi Global Rare Diseases and Bioasis will host a joint webcast with details to be announced."
